日韩欧美 a级,国产又色又爽又刺激在线观看,偷偷色噜狠狠狠狠的777米奇,浮妇高潮喷白浆视频

產(chǎn)品中心

Product center

Darunavir Ethanolate 99%

Darunavir Ethanolate

源葉(MedMol)
S80855
635728-49-3
C27H37N3O7S.C2H5OH
593.73
品牌 貨號 產(chǎn)品規(guī)格 價格(RMB) 庫存(上海) 北京 武漢 南京 購買數(shù)量
源葉(MedMol) S80855-5mg 99% ¥320.00元 10 - - -
源葉(MedMol) S80855-10mg 99% ¥490.00元 10 - - -
源葉(MedMol) S80855-50mg 99% ¥1160.00元 7 - - -
源葉(MedMol) S80855-100mg 99% ¥1700.00元 5 - - -
產(chǎn)品介紹 參考文獻 質(zhì)檢證書(COA) 摩爾濃度計算器 相關(guān)產(chǎn)品

產(chǎn)品介紹

Darunavir ethanolate (TMC114 Ethanolate) is a potent HIV protease inhibitor used to treat and prevent HIV/AIDS. Darunavir has a Ki of 1 nM for wild type HIV-1 protease.
產(chǎn)品描述: Darunavir ethanolate (TMC114 Ethanolate) is a potent HIV protease inhibitor used to treat and prevent HIV/AIDS. Darunavir has a Ki of 1 nM for wild type HIV-1 protease.
靶點: HIV-1;HIVProtease
體內(nèi)研究:
Darunavir is effective against wild-type and PI-resistant HIV, and has an oral bioavailability of 37%. It needs to be combined with ritonavir, which increases the bioavailability to 82%
參考文獻:
1. Tie Y, et al. High resolution crystal structures of HIV-1 protease with a potent non-peptide inhibitor (UIC-94017) active against multi-drug-resistant clinical strains. J Mol Biol. 2004 Apr 23;338(2):341-52. 2. McKeage K, et al. Darunavir: a review of its use in the management of HIV infection in adults. Drugs. 2009;69(4):477-503. 3. Bhalekar MR, et al. In-vivo bioavailability and lymphatic uptake evaluation of lipid nanoparticulates of darunavir. Drug Deliv. 2016 Sep;23(7):2581-2586.
溶解性: DMSO  :  ≥  50  mg/mL  (84.21  mM)
保存條件: -20℃
配置溶液濃度參考:
1mg 5mg 10mg
1 mM 1.684 ml 8.421 ml 16.843 ml
5 mM 0.337 ml 1.684 ml 3.369 ml
10 mM 0.168 ml 0.842 ml 1.684 ml
50 mM 0.034 ml 0.168 ml 0.337 ml
注意: 部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。

參考文獻

質(zhì)檢證書(COA)

如何獲取質(zhì)檢證書(COA)?
請輸入貨號和一個與之匹配的批號。
例如:
批號:C10000001 貨號:A800001-25g
在貨品標簽上如何找到貨號和批號?

摩爾濃度計算器

質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)

=
×
×

相關(guān)產(chǎn)品